Organic Letters
Letter
electron-rich and poor arylamines are tolerant of the photoredox
reaction conditions and that moderate to good levels of
diastereoselectivity can be achieved when a chiral enamide is
used. Additionally, we have demonstrated that these reaction
products can be conveniently cyclized to give valuable γ-lactams.
Our efforts in expanding this protocol using allenyl substrates are
in progress and will be reported in due course.
(3) For reviews, see: (a) Fletcher, M. D.; Campbell, M. M. Chem. Rev.
1
998, 98, 763. (b) Chorev, M.; Goodman, M. Acc. Chem. Res. 1993, 26,
2
66. (c) Goodman, M.; Chorev, M. Acc. Chem. Res. 1979, 12, 1 For other
selected examples, see:. (d) Zhu, A.; Dong, J.; Fu, S.; Jiang, H.; Zeng, W.
́
Org. Lett. 2011, 13, 4914. (e) Quelever, G.; Bihel, F.; Kraus, J. − L. Org.
́
Biomol. Chem. 2003, 1, 1676. (f) Marastoni, M.; Salvadori, S.; Bortolotti,
F.; Tomatis, R. J. J. Pept. Res. 1997, 49, 538. (g) Hwang, S. Y.; Berges, D.
A.; Taggart, J. L.; Gilvarg, C. J. J. Med. Chem. 1989, 32, 694.
(
h) Kingsbury, W. D.; Boehm, J. C.; Perry, D.; Gilvarg, C. Proc. Natl.
Acad. Sci. U. S. A. 1984, 81, 4573.
4) (a) Ruiz-Sanchis, P.; Savina, S. S.; Albericio, F.; Alvarez, M. Chem. -
Eur. J. 2011, 17, 1388. (b) Anthoni, U.; Christophersen, C.; Nielsen, P.
H. In Naturally Occuring Cyclotryptophans and Cyclotryptomins.
Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W.;
Pergamon: Oxford, 1999; Vol. 13, p 163.
ASSOCIATED CONTENT
■
́
(
*
S
Supporting Information
Experimental procedures, characterization tables, NMR
data, and X-ray table data for 21b, 21lg, 21l, 21n, 21p, and
(5) Ji, W.; Yao, L.; Liao, X. Org. Lett. 2016, 18, 628.
(6) For reviews, see: (a) Lee, Y. S.; Alam, Md. M.; Keri, R. S. Chem. -
Asian J. 2013, 8, 2906. (b) Maryanoff, B. E.; Zhang, H. − C.; Cohen, J.
H.; Turchi, I. J.; Maryanoff, C. A. Chem. Rev. 2004, 104, 1431.
(
c) Speckamp, W. N.; Moolenaar, M. J. Tetrahedron 2000, 56, 3817.
7) (a) Dagousset, G.; Carboni, A.; Magnier, E.; Masson, G. Org. Lett.
014, 16, 4340 For a review of the radical/cationic pathway, see:.
b) Courant, T.; Masson, G. J. Org. Chem. 2016, 81, 6945 Also see:.
contacting The Cambridge Crystallographic Data Centre, 12
Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033.
(
2
(
(c) Courant, T.; Masson, G. Chem. - Eur. J. 2012, 18, 423. (d) Carboni,
A.; Dagousset, G.; Magnier, E.; Masson, G. Org. Lett. 2014, 16, 1240 For
a related photoredox addition to enamides:. (e) Jiang, H.; Huang, C.;
Guo, J.; Zeng, C.; Zhang, Y.; Yu, S. Chem. - Eur. J. 2012, 18, 15158.
(
8) For reviews, see: (a) Beatty, J. W.; Stephenson, C. R. J. Acc. Chem.
AUTHOR INFORMATION
■
*
Res. 2015, 48, 1474. (b) Angnes, R. A.; Li, Z.; Correia, C. R. D.;
Hammond, G. B. Org. Biomol. Chem. 2015, 13, 9152. (c) Prier, C. K.;
Rankic, D. A.; MacMillan, D. W. C. Chem. Rev. 2013, 113, 5322.
(
d) Wallentin, C. J.; Nguyen, J. D.; Stephenson, C. R. J. Chimia 2012, 66,
ORCID
3
94. (e) Xuan, J.; Xiao, W. J. Angew. Chem., Int. Ed. 2012, 51, 6828.
Notes
(f) Shi, L.; Xia, W. Chem. Soc. Rev. 2012, 41, 7687. (g) Narayanam, J. M.
R.; Stephenson, C. R. J. Chem. Soc. Rev. 2011, 40, 102.
(
9) (a) Courant, T. D.; Dagousset, G.; Masson, G. Synthesis 2015, 47,
799. (b) Carbery, D. Org. Biomol. Chem. 2008, 6, 3455.
10) For a review on the fate of amine radicals in photoredox, see:
(a) Hu, J.; Wang, J.; Nguyen, T. H.; Zheng, N. Beilstein J. Org. Chem.
013, 9, 1977. For recent examples of arylamine functionalization under
The authors declare no competing financial interest.
1
(
ACKNOWLEDGMENTS
We gratefully acknowledge financial support from Lough-
borough University and the Tertiary Education Trust Fund
■
2
photoredox conditions, see: (b) Yu, L. − C.; Gu, J. − W.; Zhang, S.;
Zhang, X. J. Org. Chem. 2017, 82, 3943. (c) Fava, E.; Millet, A.;
Nakajima, M.; Loescher, S.; Rueping, M. Angew. Chem., Int. Ed. 2016, 55,
(
(
TETFund) Abuja, Nigeria (O.K.K.). We thank Dr. Mark Edgar
Loughborough) for NMR structure determination. The
6
776. (d) Cheng, J.; Deng, X.; Wang, G.; Li, Y.; Cheng, X.; Li, G. Org.
Advanced Light Source is supported by the Director, Office of
Science, Office of Basic Energy Sciences, of the U.S. Department
of Energy under Contract No. DE-AC02-05CH11231. We
acknowledge support of the EPSRC via grant EP/M027341/1.
Lett. 2016, 18, 4538.
(11) For an example of stereodefined N,N-acetal formation, see:
(a) Vink, M. K. S.; Schortinghuis, C. A.; Mackova-Zabelinskaja, A.;
Fechter, M.; Pochlauer, P.; Castelijns, A. M. C. F.; van Maarseveen, J. H.;
Hiemstra, H.; Griengl, H.; Schoemaker, H. E.; Rutjes, F. P. J. T. Adv.
Synth. Catal. 2003, 345, 483. (b) Wijdeven, M. A.; Wijtmans, R.; van den
Berg, R. J. F.; Noorduin, W.; Schoemaker, H. E.; Sonke, T.; van Delft, F.
L.; Blaauw, R. H.; Fitch, R. W.; Spande, T. F.; Daly, J. W.; Rutjes, F. P. J.
T. Org. Lett. 2008, 10, 4001.
REFERENCES
■
(
1
1) (a) Ye, L. − W.; Shu, C.; Gagosz, F. Org. Biomol. Chem. 2014, 12,
833. (b) Kosugi, Y.; Hamaguchi, H.; Nagasaka, T.; Ozawa, N.; Ohki, S.
Heterocycles 1980, 14, 1245. (c) McCaully, R. J.; Bell, S. C. US Patent
US-3474093, 1969. (d) Fabre, J.-L.; Fabre, D.; James, C.; Lave, D. US
Patent US-4547504, 1985. (e) Ohki, S.; Hamaguchi, H.; Nagasaka, T.;
Kikuchi, H. US Patent US-4464361, 1984. (f) Axrten, J. M.; Medina, J.
R. GlaxoSmithKline Co, UK WO 2015/136463, 2015. (g) Dumitriu, G.
(
12) Caruano, J.; Muccioli, G. G.; Robiette, R. Org. Biomol. Chem.
016, 14, 10134.
13) The diastereoisomers could not be separated chromato-
graphically.
2
(
(
−
M.; Bîcu, E.; Eryuruk, U.; Belei, D.; Rigo, B.; Daïch, A.; Ghinet, A.
Synlett 2016, 27, 934.
2) (a) Hiramatsu, K.; Honjo, T.; Rauniyar, V.; Toste, F. D. ACS Catal.
016, 6, 151. (b) Englund, E. E.; Neumann, S.; Eliseeva, E.; McCoy, J.
(
2
G.; Titus, S.; Zheng, W.; Southall, N.; Shinn, P.; Leister, W.; Thomas, C.
J.; Inglese, J.; Austin, C. P.; Gershengorn, M. C.; Huang, W.
MedChemComm 2011, 2, 1016. (c) Shetty, B. V.; Campanella, L. A.;
Thomas, T. L.; Fedorchuk, M.; Davidson, T. A.; Michelson, L.; Volz, H.;
Zimmerman, S. E. J. Med. Chem. 1970, 13, 886. (d) Cohen, E.; Klarberg,
B.; Vaughan, J. R., Jr J. Am. Chem. Soc. 1960, 82, 2731. (e) Pinza, M.;
Farina, C.; Cerri, A.; Pfeiffer, U.; Riccaboni, M. T.; Banfi, S.; Biagetti, R.;
Pozzi, O.; Magnani, M.; Dorigotti, L. J. Med. Chem. 1993, 36, 4214.
D
Org. Lett. XXXX, XXX, XXX−XXX